Seller record · Telehealth service

Ivim Health

Fails 2 of 8 criteria. S3, pharmacy identification: Ivim states it selects FDA-inspected, state-regulated compounding pharmacies, and it names no facility anywhere on the site. 1 more criterion also fails; see the table below.

At a glance

Ivim HealthTelehealth service

6/8criteria passed
Price
Printed on its own pages before sign-up
Sells
compounded semaglutide, compounded tirzepatide, brand GLP-1 drugs, and 1 more
FDA letters
1 on file
Visit Ivim HealthSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded GLP-1 drugs on fixed multi-month plans. An FDA warning letter names the operating entity at the address its terms print.

Operating entity Ivim Services LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSIvim Health's about page; Ivim Health's HIPAA notice
S2Prescription gatingPASSIvim Health's form page on its patient site
S3Pharmacy identificationFAILIvim Health's compounded semaglutide page
S4Compounding disclosurePASSIvim Health's compounded semaglutide page
S5Analytical documentationFAILIvim Health's sitemap index page
S6Business addressPASSIvim Health's terms and conditions
S7Price disclosurePASSIvim Health's GLP-1 pricing page
S8Enforcement statusPASSFDA's website; FDA warning letter 721816

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSDr. Jessica Duncan, MD, DABOM is named as chief medical officer, and six affiliated telehealth practices are named in the privacy notice.Source: Ivim Health's about page; Ivim Health's HIPAA notice.
S2PASSThe first intake question, which asks where the buyer is in their health journey, stops the order.Source: Ivim Health's form page on its patient site.
S3FAILIvim states it selects FDA-inspected, state-regulated compounding pharmacies, and it names no facility anywhere on the site.Source: Ivim Health's compounded semaglutide page.
S4PASSCompounded medications are not FDA-approved and do not undergo the same rigorous testing, printed on the compounded semaglutide page.Source: Ivim Health's compounded semaglutide page.
S5FAILNo certificate, lot report or test document appears on the safety pages, the pricing page, or anywhere else on the site.Source: Ivim Health's sitemap index page.
S6PASSIvim Services LLC at 4200 Regent Street, Suite 200, Columbus, OH 43219 in the terms, which also give a registered office in Flint, Michigan.Source: Ivim Health's terms and conditions.
S7PASSCompounded semaglutide is printed at 600 dollars for a 6-month plan and 499 dollars for a 4-month plan, with membership at 75 dollars per month afterward.Source: Ivim Health's GLP-1 pricing page.
S8PASSFDA warning letter 721816, February 2026, names Ivim Services LLC doing business as Ivim at 4200 Regent Street, Suite 200, Columbus, Ohio, the address its own terms print. It alleges that the products pictured on the website identify Ivim on the label, suggesting Ivim is the compounder of those drugs when it is not. No close-out letter appears in the index. No FDA action has halted the business, and the seller still trades.Source: FDA's website; FDA warning letter 721816.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand GLP-1 drugs, vitamin injections.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatide

Enforcement documents on file: 1 warning letter

FDA warning letter 721816, issued February 2026, to Ivim Services LLC dba IvimPictured labels identify Ivim as the compounder of semaglutide and tirzepatide products when it is not, which misbrands the products.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Ivim Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.